- Home
- Products
AGRYLIN (Anagrelide Hydrochloride)
AGRYLIN (Anagrelide Hydrochloride)
- Generic Name: Anagrelide Hydrochloride
- Dosage Form & Strength: 0.5 mg and 1 mg
- Form: Oral Capsules
Agrylin (Anagrelide Hydrochloride) is a prescription medicine used to treat thrombocythemia secondary to myeloproliferative disorders. It helps reduce elevated platelet counts, thereby lowering the risk of thrombosis and thrombo-hemorrhagic events. The treatment also alleviates associated symptoms and improves overall patient outcomes.
- Use of anagrelide is not recommended in patients with severe hepatic impairment due to an increased risk of adverse effects.
- Patients with moderate liver impairment should be administered a reduced dosage and monitored closely, particularly for cardiovascular events.
- Patients with existing or suspected cardiac conditions should use anagrelide with caution, only if the benefits outweigh the risks.
- Liver function tests (ALT, AST) should be assessed prior to and during treatment with anagrelide to ensure safe use.
To legally import Anagrelide Hydrochloride through GlobalRareMeds, the following documentation is required:
- Valid prescription from a qualified physician
- Patient’s diagnostic reports
- Government-issued ID of the patient
Order Confirmation:
Orders will be processed only after submission and verification of the prescription and, if required, an import permit.
Anagrelide Hydrochloride is a prescription-only medication and can be made available across major Indian cities such as Mumbai, Delhi, Kolkata, Chennai, Hyderabad, Ahmedabad, Bangalore, Pune, Lucknow, and more, in compliance with regulatory guidelines.
GlobalRareMeds sources Anagrelide Hydrochloride from licensed pharmaceutical distributors and manufacturers across Canada, USA, Europe, and Australia.
We ensure safe and timely delivery of medicines from our fulfillment center in Ambernath, Thane District, after necessary verification.
All prescriptions are reviewed by registered pharmacists before dispatch, and shipments are sent directly to the patient’s address.
For Pricing and Orders:
📧 Email: info@globalraremeds.com
📞 Call/WhatsApp: +91-99675 15602
Q. What is the generic name of Agrylin?
A. The generic name is Anagrelide Hydrochloride.
Q. Who manufactures Agrylin?
A. Agrylin is manufactured by Shire US Inc.
Q. Is Agrylin FDA approved?
A. Yes, Agrylin was approved by the FDA in March 1997.
Q. In what forms is Agrylin available?
A. Agrylin is supplied as oral capsules in 0.5 mg and 1 mg strengths.
Q. What conditions does Agrylin treat?
A. It is used to treat thrombocythemia associated with myeloproliferative disorders, helping to reduce platelet count and related complications.
Q. How can I buy Anagrelide in India?
A. Patients can request access to Anagrelide via GlobalRareMeds, provided they have a valid prescription. Orders are processed after compliance with applicable laws.
Q. What are the precautions while using Agrylin?
A. Patients with liver or heart conditions should be closely monitored. Liver function tests and cardiovascular assessments are essential during treatment.
Q. Is Agrylin available across India?
A. Yes, Agrylin can be delivered to most major Indian cities through GlobalRareMeds, based on regulatory compliance and documentation.
Contact Patient Support
If you have questions about your order, need assistance with documentation, or require support with medicine availability, our GlobalRareMeds Patient Support Team is here to help. We aim to respond within 24 hours, Monday to Friday, between 9:00 AM and 10:00 AM IST.
info@globalraremeds.com
Phone
+91 99675 15602
+91 99675 15602
Disclaimer
All trademarks, brands, and product names featured on this website are the property of their respective owners. GlobalRareMeds does not claim ownership or affiliation unless explicitly stated. Our role is to provide reliable and transparent access to difficult-to-source medicines through named-patient import services, based on valid prescriptions and legal requirements.
The product-related content on this website is shared to the best of our knowledge, compiled from publicly available sources and regulatory documents. However, GlobalRareMeds does not guarantee the accuracy, completeness, or timeliness of this information. We strongly recommend that all medical decisions, including usage and dosage, be made only in consultation with the prescribing doctor. GlobalRareMeds assumes no responsibility for consequences arising from reliance on this information without appropriate medical guidance
